Hoffmann-la Roche
Clinical trials sponsored by Hoffmann-la Roche, explained in plain language.
-
New hope for kids with MS: drug trial targets relapses
Disease control Not yet recruitingThis study tests a drug called ocrelizumab in children and teens aged 10 to 17 with relapsing-remitting multiple sclerosis (MS). The goal is to see how the drug works in the body, if it is safe, and how well it controls MS attacks. Participants will receive injections over 48 wee…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
New hope for myeloma patients: drug combo aims to deepen remission
Disease control Not yet recruitingThis study tests whether adding the experimental drug cevostamab to standard medications (pomalidomide and dexamethasone) works better than current treatments for multiple myeloma. About 380 adults who have already tried 1-3 prior therapies will participate. The goal is to see if…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 09:34 UTC